CXCL10 and tuberculosis: Data from countries with a moderate or low TB burden suggested that when used as a target, the IP-10 protein yielded a higher positive rate (66.7%) of diagnosing M. tb infection than the IGRAs (52.4%) among HIV-infected persons.